CLDX icon

Celldex Therapeutics
CLDX

Overview Fund Activity

167 hedge funds and large institutions have $2.15B invested in Celldex Therapeutics in 2022 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 50 increasing their positions, 57 reducing their positions, and 17 closing their positions.

Holders
167
Holders Change
+9
Holders Change %
+5.7%
% of All Funds
2.69%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.1%
New
27
Increased
50
Reduced
57
Closed
17
Calls
$35.1M
Puts
$17.1M
Net Calls
+$18M
Net Calls Change
+$6.66M

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$207M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$22.5M
3
Jennison Associates
3
Jennison Associates
New York
$69.3M
4
TCMG
4
TSP Capital Management Group
New Jersey
$12M
5
PCH
5
Polar Capital Holdings
United Kingdom
$69.1M

Top Sellers

1
State Street
1
State Street
Massachusetts
$102M
2
Citadel Advisors
2
Citadel Advisors
Florida
$33.9M
3
EAM
3
Eventide Asset Management
Massachusetts
$65.2M
4
Goldman Sachs
4
Goldman Sachs
New York
$20M
5
ACP
5
Acuta Capital Partners
California
$5.13M
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$315M 7,064,974 +49,131 +0.7%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$207M 4,647,912 +1,567,179 +51%
BlackRock
3
BlackRock
New York
$144M 3,224,716 +94,303 +3%
RI
4
RTW Investments
New York
$137M 3,084,215 – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$112M 2,513,564 +38,183 +2%
State Street
6
State Street
Massachusetts
$102M 2,291,454 -880,124 -28%
RCM
7
RA Capital Management
Massachusetts
$92.5M 2,075,000 – –
RG
8
Redmile Group
California
$88.1M 1,977,451 -7,700 -0.4%
BG
9
Bellevue Group
Switzerland
$80.2M 1,800,000 – –
KCM
10
Kynam Capital Management
New Jersey
$71.6M 1,605,390 +5,263 +0.3%
Jennison Associates
11
Jennison Associates
New York
$69.3M 1,555,318 +281,297 +22%
PCH
12
Polar Capital Holdings
United Kingdom
$69.1M 1,550,000 +101,066 +7%
EAM
13
Eventide Asset Management
Massachusetts
$65.2M 1,463,050 -328,750 -18%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$39.4M 883,535 +30,829 +4%
T. Rowe Price Associates
15
T. Rowe Price Associates
Maryland
$37.1M 833,009 +87,001 +12%
OCA
16
Octagon Capital Advisors
New York
$33.9M 761,398 – –
Citadel Advisors
17
Citadel Advisors
Florida
$33.9M 760,254 -740,840 -49%
Marshall Wace
18
Marshall Wace
United Kingdom
$29.7M 666,749 +14,028 +2%
EP
19
Eversept Partners
New York
$24.9M 558,774 -67,598 -11%
FAM
20
Fred Alger Management
New York
$23.2M 520,872 +77,230 +17%
Point72 Asset Management
21
Point72 Asset Management
Connecticut
$22.5M 505,800 +370,800 +275%
CC
22
Commodore Capital
New York
$22.1M 495,823 -42,989 -8%
CS
23
Candriam SCA
Luxembourg
$21.8M 488,509 +70,000 +17%
Goldman Sachs
24
Goldman Sachs
New York
$20M 449,584 -214,847 -32%
Northern Trust
25
Northern Trust
Illinois
$19.4M 434,612 +12,371 +3%
1
2 3 4 5